CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 80 enrolled
Drug / intervention
Normal Saline Flush, 0.9% Injectable Solution_#1 +1 moredrug
Likely dose
Ketamine Hydrochloride 0.5mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02925858
NCT02925858Phase 4Completed

Pilot Study: The Effect of Intraoperative Ketamine on Analgesia Post-Cardiac Surgery and Prevention of Chronic Pain

Jewish General Hospital·interventional·Posted Oct 6, 2016·Updated Sep 6, 2019

In Brief

A Phase 4 clinical trial evaluating Normal Saline Flush, 0.9% Injectable Solution_#1 and Ketamine Hydrochloride for Pain, Postoperative. Completed, enrolled 80 participants across 1 site.

Detailed Summary

Randomized, controlled, double-blind pilot study evaluating the effect of an intraoperative infusion of intravenous Ketamine on the quantity of opioid consumed postoperatively in coronary artery bypass surgery patients receiving a median sternotomy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesCanada
Collaborators--

Timeline

Phase 4CompletedFinished
2017201820192020202120222023202420252026
First PostedOct 6, 2016
Enrollment StartAug 28, 2017
Primary CompletionNov 1, 2018
Study CompletionNov 27, 2018
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 9.7 years ago

Interventions

Normal Saline Flush, 0.9% Injectable Solution_#1drug

Normal saline infusion mimicking infusion rate of ketamine for a given weight

Ketamine Hydrochloridedrug

Ketamine IV infusion (0.5mg/kg bolus prior to incision, 0.5mg/kg/hr until the end of surgery)